Biofrontera Inc Cash Flow-to-Debt Ratio
Biofrontera Inc cash flow-to-debt ratio. Biofrontera Inc (BFRI) has a Cash Flow-to-Debt Ratio of -0.09x as of June 2026, meaning its operating cash flow of $-1.66 Million could theoretically repay 0% of its total liabilities ($18.11 Million) in one year. Check Biofrontera Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Biofrontera Inc (2019–2025)
Cash flow-to-debt ratio of Biofrontera Inc from 2019 to 2025. Historical debt coverage capacity for Biofrontera Inc across 7 annual periods. Check Biofrontera Inc (BFRI) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Biofrontera Inc Cash Flow-to-Debt Ratio by Year (2019–2025)
Biofrontera Inc cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Biofrontera Inc. For the full cash flow conversion analysis, see cash flow conversion of Biofrontera Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.74x | $-13.36 Million | $18.08 Million | ▼ -27.1% |
| 2024 | -0.58x | $-10.27 Million | $17.67 Million | ▲ +46.0% |
| 2023 | -1.08x | $-24.89 Million | $23.14 Million | ▼ -79.4% |
| 2022 | -0.60x | $-16.20 Million | $27.01 Million | ▲ +6.0% |
| 2021 | -0.64x | $-26.71 Million | $41.88 Million | ▲ +5.6% |
| 2020 | -0.68x | $-12.37 Million | $18.31 Million | ▼ -5.7% |
| 2019 | -0.64x | $-37.68 Million | $58.93 Million | — |